Evidence map›Paper›PMID 41356823›Full record

ArticleFrontiers in nutrition2025

Ping Kong, Yibo Xian, Canshan Lao, Baojia Huang, Dongya Zhang, Lihong Tai, Yingying Zhao, Zilun Pu, Zhou Lan, Chenchen Zhang and 11 more

Abstract read
In one paragraph

Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Ping Kong *Moon (Guangzhou) Biotech Co. Ltd., Guangzhou, Guangdong, China.
Yibo Xian *Moon (Guangzhou) Biotech Co. Ltd., Guangzhou, Guangdong, China.
Canshan LaoMoon (Guangzhou) Biotech Co. Ltd., Guangzhou, Guangdong, China.
Baojia HuangMoon (Guangzhou) Biotech Co. Ltd., Guangzhou, Guangdong, China.
Dongya ZhangMoon (Guangzhou) Biotech Co. Ltd., Guangzhou, Guangdong, China.
Lihong TaiMoon (Guangzhou) Biotech Co. Ltd., Guangzhou, Guangdong, China.
Yingying ZhaoMoon (Guangzhou) Biotech Co. Ltd., Guangzhou, Guangdong, China.
Zilun PuMoon (Guangzhou) Biotech Co. Ltd., Guangzhou, Guangdong, China.
Zhou LanMoon (Guangzhou) Biotech Co. Ltd., Guangzhou, Guangdong, China.
Chenchen ZhangMoon (Guangzhou) Biotech Co. Ltd., Guangzhou, Guangdong, China.
Zhenzhen LiuMoon (Guangzhou) Biotech Co. Ltd., Guangzhou, Guangdong, China.
Chen XiaoMoon (Guangzhou) Biotech Co. Ltd., Guangzhou, Guangdong, China.
Guozhen ZhaoMoon (Guangzhou) Biotech Co. Ltd., Guangzhou, Guangdong, China.
Ruijuan ZhuMoon (Guangzhou) Biotech Co. Ltd., Guangzhou, Guangdong, China.
Yajun LiangMoon (Guangzhou) Biotech Co. Ltd., Guangzhou, Guangdong, China.
Chuan-Sheng LinMoon (Guangzhou) Biotech Co. Ltd., Guangzhou, Guangdong, China.
Jing-Han LinState Key Laboratory of Microbial Diversity and Innovative Utilization, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Jing-Zu SunState Key Laboratory of Microbial Diversity and Innovative Utilization, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Tao WangState Key Laboratory of Microbial Diversity and Innovative Utilization, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Hong-Wei LiuState Key Laboratory of Microbial Diversity and Innovative Utilization, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Xianzhi JiangMoon (Guangzhou) Biotech Co. Ltd., Guangzhou, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The intestinal microbiota has been demonstrating a strong correlation with the etiology and progression of obesity and metabolic disorders, thus presenting a novel approach to addressing this issue. In this study, we screened and revealed the anti-obesity efficacy of the viable

Indexed as

anti-obesityChristensenella intestinihominisGLP-1insulin resistancemetabolic disordersNASHprobioticSCFAs

Identifiers

PMID41356823
PMCPMC12677068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.